Research Paper Volume 15, Issue 19 pp 10305—10329
The integrated single-cell analysis developed an immunogenic cell death signature to predict lung adenocarcinoma prognosis and immunotherapy
Figure 4. Assessment of risk models. (A) Kaplan-Meier survival analysis of signatures in the TCGA and five GEO datasets. (B) Observation of the distribution of samples in high- and low-risk groups using PCA analysis.